PARODI, OBERDAN
 Distribuzione geografica
Continente #
AS - Asia 2.475
NA - Nord America 1.487
EU - Europa 606
SA - Sud America 505
AF - Africa 45
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.123
Nazione #
US - Stati Uniti d'America 1.401
SG - Singapore 1.067
CN - Cina 511
BR - Brasile 411
VN - Vietnam 248
HK - Hong Kong 240
FR - Francia 131
IT - Italia 123
BD - Bangladesh 117
NL - Olanda 100
KR - Corea 84
FI - Finlandia 67
DE - Germania 58
JP - Giappone 56
IN - India 39
CA - Canada 38
GB - Regno Unito 36
AR - Argentina 32
MX - Messico 24
ID - Indonesia 20
IQ - Iraq 17
EC - Ecuador 16
AT - Austria 12
PL - Polonia 11
PY - Paraguay 11
TR - Turchia 11
SA - Arabia Saudita 10
CO - Colombia 9
IE - Irlanda 9
ZA - Sudafrica 9
CL - Cile 8
IL - Israele 8
MA - Marocco 8
PK - Pakistan 8
PE - Perù 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
ES - Italia 6
RU - Federazione Russa 6
SE - Svezia 6
VE - Venezuela 6
HN - Honduras 5
JM - Giamaica 5
UA - Ucraina 5
AL - Albania 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
KE - Kenya 4
LT - Lituania 4
NG - Nigeria 4
PT - Portogallo 4
BE - Belgio 3
CR - Costa Rica 3
HU - Ungheria 3
JO - Giordania 3
LV - Lettonia 3
NO - Norvegia 3
PH - Filippine 3
TH - Thailandia 3
TN - Tunisia 3
UZ - Uzbekistan 3
AO - Angola 2
AU - Australia 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GP - Guadalupe 2
GT - Guatemala 2
IR - Iran 2
LB - Libano 2
SN - Senegal 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
Totale 5.117
Città #
Singapore 645
Santa Clara 460
Hong Kong 235
Hefei 164
San Jose 152
Beijing 126
Lauterbourg 116
Ashburn 112
Seoul 82
Dallas 77
Los Angeles 70
Ho Chi Minh City 69
Hanoi 64
Helsinki 57
Tokyo 46
New York 42
São Paulo 29
Nuremberg 19
Buffalo 18
Naples 17
Belo Horizonte 15
Da Nang 15
Toronto 15
Phoenix 14
Chicago 11
Haiphong 11
Warsaw 11
Falkenstein 10
Florence 10
Frankfurt am Main 10
Milan 10
Orem 10
Vienna 10
Düsseldorf 9
Montreal 9
Rome 9
Baghdad 8
Minamishinagawa 8
Campinas 7
Fortaleza 7
Mexico City 7
Mumbai 7
Palermo 7
Rio de Janeiro 7
Amsterdam 6
Atlanta 6
Chennai 6
Curitiba 6
Guarulhos 6
Guayaquil 6
Johannesburg 6
London 6
Manchester 6
Porto Alegre 6
Stockholm 6
Turku 6
Ankara 5
Bengaluru 5
Biên Hòa 5
Brasília 5
Brooklyn 5
Columbus 5
Denver 5
Dublin 5
Houston 5
Hải Dương 5
Jeddah 5
Las Vegas 5
Newark 5
Osasco 5
Quảng Ngãi 5
Recife 5
Salvador 5
Santiago 5
Santo André 5
Sorocaba 5
Baku 4
Boardman 4
Bắc Giang 4
Catania 4
Chengdu 4
Ciudad del Este 4
Dhaka 4
Goiânia 4
Guangzhou 4
Juiz de Fora 4
Lappeenranta 4
Lisbon 4
Livorno 4
Nairobi 4
Phủ Lý 4
São José do Rio Preto 4
Tampa 4
Thái Bình 4
Asunción 3
Belford Roxo 3
Betim 3
Bogotá 3
Brescia 3
Brussels 3
Totale 3.099
Nome #
SMARTool: Interim Progress Report (M19-M30) 128
SMARTool - Periodic Technical Report - PART B (Period 2) 113
Impact of normalization strategy on cardiac expression of pro-inflammatory cytokines: Evaluation of reference genes in different human myocardial regions after Left Ventricular Assist Device support. 83
Prognostic and clinical correlates of angiographically diffuse non-obstructive coronary lesions 76
A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome 76
Upregulation of chemokine receptor CXCR4 and caspase-dependent apoptosis genes can synergistically favour activation of endothelial cells exposed to low shear stress 71
Computing of low shear stress-driven endothelial gene network involved in early stages of atherosclerotic process 67
Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS) 66
DOREMI - Final report from the pilot site 63
DOREMI - Interim Progress Report (Period 1) 62
Blood gluthatione as a marker of cardiac allograft vasculopathy in heart transplant recipients 59
Low leptin plasma levels are associated with progression of coronary atherosclerosis in patients with stable coronary artery disease from the SMARTool Study 59
Modulation of lipid homeostasis in response to continuous or intermittent high-fat diet in pigs 59
Designing User Interfaces for a Wellbeing Persuasive App 59
DOREMI - Annual periodic report (Period2) 58
Progettazione delle interfacce e dek workflow funzionale della App Mensana 58
Visualization and simulated surgery of the left ventricle in the virtual pathological heart of the Virtual Physiological Human 57
Reliability and human factors in Ambient Assisted Living environments. The DOREMI case study 57
Detecting the impact of emerging cardiovascular risk factors: the role of positron emission tomography 55
SMARTool: Periodic Technical Report - Part B 55
Myocardial interleukin-6 in the setting of left ventricular mechanical assistance: relation with outcome and C-reactive protein. 55
DOREMI - Annual periodic report (Period 1) 54
Innate Immunity and Coronary Atherosclerosis Progression: putative cellular and molecular marker. 54
HDL-MEDIATED ATHEROPROTECTION IN A HIGH CHOLESTEROL DIET SWINE MODEL BY QUANTITATIVE (IMMUNO)HISTOLOGY CORONARY PROFILING 54
Application of the sequence organ failure assessment score to cardiac surgical patients 53
Biohumoral predictors of coronary atherosclerosis progression in patients with suspected coronary artery disease from the SMARTool Study 52
Early Expression of Pro- and Anti-Inflammatory Cytokines in Left Ventricular Assist Device Recipients With Multiple Organ Failure Syndrome 51
Detecting socialization events in ageing people: the experience of the DOREMI project 51
SMARTool - Interim Report M19-M24 51
Womersley Number-Based Estimates of Blood Flow Rate in Doppler Analysis: In Vivo Validation by Means of Phase-Contrast MRI 50
Noninvasive CT-based hemodynamic assessment of coronary lesions derived from fast computational analysis: a comparison against fractional flow reserve 50
A learning system for automatic Berg Balance Scale score estimation 49
DOREMI - Dissemination Plan 48
Smart environments and context-awareness for lifestyle management in a healthy active ageing framework. 48
ICT solution for balance assessment in elderly: the DOREMI system validation and applicability 47
Coronary blood flow, metabolism and function in dysfunctional viable miocardium before and early after surgical revascularization 47
Time-course of plasma NT-pro C-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant. 46
A reservoir computing approach for balance assessment 46
Left ventricular modelling: a quantitative functional assessment tool based on cardiac magnetic resonance imaging 46
Metodo per la separazione dei costituenti di miscele complesse di proteine da sottoporre ad analisi proteomica e apparecchiatura che attua tale metodo 45
Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy 45
Structural abnormalities of the coronary arterial wall--in addition to luminal narrowing--affect myocardial blood flow reserve. 45
GENETIC MARKERS IN CARDIAC RESYNCHRONIZATION THERAPY TREATMENT SUCCESS 44
A reservoir computing approach for balance assessment 43
Lo stress ossidativo e l'attivazione dell'infiammazione nello scompenso cardiaco terminale non migliorano durante la prima fase (1 mese) dopo impianto di assistenza ventricolare meccanica sinistra (LVAD) 43
Secretome modulation by high-cholesterol diet in pig coronary arteries 43
Predizione di crescita della placca aterosclerotica e supporto decisionale: il progetto ARTreat 42
Blood glutathione as independent marker of lipid peroxidation in heart failure 42
Relationship of endothelial shear stress with plaque features with Coronary CT Angiography and vasodilating capability with PET 42
Modulation of erythrocyte sensitivity to oxidative stress by transient hyperhomocysteinemia in healthy subjects and in patients with coronary artery disease. 42
IL-33/ST2 pathway and classical cytokines in end-stage heart failure patients submitted to left ventricular assist device support: A paradoxic role for inflammatory mediators? 40
Site-specific secretome map evidences VSMC-related markers of coronary atherosclerosis grade and extent in the hypercholesterolemic swine 40
Quantitative CTA analysis of coronary plaque progression in SMARTool clinical study: the association between baseline clinical parameters and plaque progression 40
DOREMI - Interim Progress Report (Period 2) 38
Predictive value of EuroScore on long term outcome in cardiac surgery patients: a single institution study 38
Osteopontin plasma levels increase in end-stage heart failure patients supported by left ventricular assist device implant. 38
Super-normal Tl-201 retention in hibernating myocardium: an ex-vivo study using the failing human heart 37
Time-course of plasma NT-proc-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant. 37
Osteopontin plasma levels increase in end-stage heart failure patients supported by left ventricular assist device implant. 37
High peripheral levels of h-FABP are associated with poor prognosis in end-stage heart failure patients with mechanical circulatory support 37
Non-enhanced micro-CT of paraffin embedded coronary vessels: a tool for experimental atherosclerosis 36
Preventing cognitive decline, sedentariness and malnutrition: the DOREMI approach 36
BIOLOGICAL AND INSTRUMENTAL MARKERS OF ENDOTHELIAL DYSFUNCTION IN CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY) 36
Quantitative CTA Analysis of Coronary Plaque Progression in SMARTool Clinical Study: The Association Between Baseline Clinical Parameters and Plaque Progression 35
Healthy active ageing supported by technological environment: the DOREMI experience 35
DOREMI - Data preparation and models assessment specification 35
Quantitative micro-CT based coronary artery profiling using interactive local thresholding and cylindrical coordinates. 35
Plasma glutathione levels are independently associated with ?-glutamyltransferase activity in subjects with cardiovascular risk factors 34
Smart devices and applications for healthy ageing 34
Time-course of plasma NT-proc-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant 34
Oxidative stress and thiol redox state in patients with coronary and carotid artery atherosclerosis 34
Severity of oxidative stress and inflammatory activation in end-stage heart failure patients are unaltered after 1 month of left ventricular mechanical assistance 33
Oxidative stress and inflammatory activation in end-stage heart failure do not ameliorate during early phase (1 month) of left ventricular mechanical assistance 33
Low plasma glutathione levels after reperfused acute myocardial infarction are associated with late cardiac events 33
A patient-specific computational analysis from imaging for annuloplasty ring assessment for the treatment of ischemic mitral regurgitation 33
Pre-operative interleukin-6 levels and pronounced postoperative inflammatory response are associated to INTERMACS profile before left ventricular assist device implantation 33
Genetic variants associated to reverse remodelling after cardiac resynchronization therapy 32
In vivo assessment of the chemistry of biological processes with Positron Emission Tomography 32
Functional derangement and cardiac innervation in the apical ballooning syndrome: a 123I-meta-iodobenzylguanidine scintigraphic and dobutamine stress echocardiographic study 32
Reduced myocardial MMP-2, MMP-9 and gluatione peroxidase activities and elevated cytokine levesl in patients supported by left ventricular assist device 32
Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin 32
Methionine challenge paradoxically induces a greater activation of the antioxidant defence in subjects with hyper- vs normohomocysteinemia 32
Cardiovascular risck burden, gamma-glutamyltransferase and redox state: an emerging link 32
Paraoxonase 1 L55M, Q192R and paraoxonase 2 S311C alleles in atherothrombosis 31
Identification of genetic markers for treatment success in heart failure patients insight from cardiac resynchronization therapy 31
Phenotype Changes of Circulating Monocytes in a Hypercholesterolemic Swine Model of Coronary Artery Disease 31
Glutamate-cysteine ligase polymorphism, hypertension, and male sex are associated with cardiovascular events. Biochemical and genetic characterization of Italian subpopulation 31
Assessment of pulmonary arterial pressure during exercise-Doppler echocardiography in systemic sclerosis 31
Quantitative approach to regional blood flow distribution and wall motion using microsphere myocardial scintigraphy in man 31
Development and Validation of Automated Endocardial and Epicardial Contour Detection for MRI Volumetric and Wall Motion Analysis 29
Myocardial Perfusion Imaging Evidence of Functionally Complete Revascularization by Minimally Invasive Direct Coronary Artery Bypass in Two-Vessel Coronary Artery Disease 29
ARTreat Project: Three-Dimensional Numerical Simulation of Plaque Formation and Development in the Arteries 29
Genetic variants associated to reverse remodelling after cardiac resynchronization therapy 29
Does left ventricular assist device implantation modulate the cardiac cell apoptosis in end-stage heart failure? 29
Plaque progression modeling by using computer simulation and imaging data 29
Computerized methodology for micro-CT and histological data inflation using an IVUS based translation map 28
Genetic variants of the renin-angiotensin-aldosterone system and reverse remodeling after cardiac resynchronization therapy 27
Myocardial redox state alterations and elevated cytokines levels in patients with end stage heart failure (ESHF) supported by left ventricular assist device (LVAD) 26
False incoagulable PT-INR results in oral anticoagulant therapy 26
Reduction of cardiac metalloproteinase activity is sustained by amelioration of GSH bioavailability during left ventricular assist device support in failing heart. 26
Totale 4.457
Categoria #
all - tutte 18.123
article - articoli 12.357
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 145
Totale 30.625


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202425 0 0 0 0 0 0 0 0 1 4 20 0
2024/20251.869 19 5 156 80 386 130 24 60 40 149 452 368
2025/20263.130 120 225 336 468 560 145 465 140 164 167 192 148
2026/2027118 118 0 0 0 0 0 0 0 0 0 0 0
Totale 5.142